translate
gl
arrow_drop_down
translate
gl
arrow_drop_down
es
en
Identifícate
Portal da
INVESTIGACIÓN
Grupos
Investigadores/as
Resultados
Oncoloxía
Centre Hospitalier de l’Université de Montréal
Montreal, Canadá
Estás en
Colaboracións
Centre Hospitalier de l’Université de Montréal
Publicacións en colaboración con investigadores/as de Centre Hospitalier de l’Université de Montréal (3)
2023
Second-line treatment outcomes after progression from first-line chemotherapy plus immunotherapy in patients with advanced non-small cell lung cancer
Lung Cancer, Vol. 178, pp. 116-122
2020
Correction: NSABP FB-7: A phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2+ breast cancer (Breast Cancer Research (2019) 21 (133) DOI: 10.1186/s13058-019-1196-y)
Breast Cancer Research
2019
NSABP FB-7: A phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2+ breast cancer
Breast Cancer Research, Vol. 21, Núm. 1
